Literature DB >> 8370953

Age incidence of meningococcal infection England and Wales, 1984-1991.

D M Jones1, R H Mallard.   

Abstract

The age incidence of meningococcal infections occurring between 1984 and 1991 in England and Wales was determined from data submitted with isolates to the Meningococcal Reference Laboratory for England and Wales. The incidence was maximum at 6 months of age and thereafter declined sharply to the age of 4 years. It was followed by a small secondary peak at 17-18 years. There was a relative excess of group B infections in the early months of life and, although group B and group C infections both peaked at 6 months of age, the latter did not decline until after the age of 9 months. Certain strains of meningococci were more likely to be associated with disease in older children and young adults.

Entities:  

Mesh:

Year:  1993        PMID: 8370953     DOI: 10.1016/0163-4453(93)93978-d

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  Managing meningococcal disease case clusters: art or science?

Authors:  K Ardern; S Bowler; R M Hussey; C M Regan
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

2.  Secondary prevention of meningococcal disease. British guidelines should have been considered.

Authors:  D M Jones
Journal:  BMJ       Date:  1996-06-15

3.  Preventative strategies on meningococcal disease.

Authors:  R T Mayon-White; P T Heath
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

4.  Relationships Between Clinico-Epidemiological Patterns of Invasive Meningococcal Infections and Complement Deficiencies in French South Pacific Islands (New Caledonia).

Authors:  Maguy Daures; Michele John; Cécile Veysseyre Balter; Olivier Simon; Yann Barguil; Isabelle Missotte; Jean-Paul Grangeon; Sylvie Laumond-Barny; Martine Noel; Laurent Besson-Leaud; Pierre-Emmanuel Spasic; Aurélie de Suremain; Ann-Claire Gourinat; Elodie Descloux
Journal:  J Clin Immunol       Date:  2014-10-29       Impact factor: 8.317

5.  Risk and protective factors for meningococcal disease in adolescents: matched cohort study.

Authors:  Joanna Tully; Russell M Viner; Pietro G Coen; James M Stuart; Maria Zambon; Catherine Peckham; Clare Booth; Nigel Klein; Ed Kaczmarski; Robert Booy
Journal:  BMJ       Date:  2006-02-10

6.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996.

Authors:  B Vlaminckx; W van Pelt; L Schouls; A van Silfhout; C Elzenaar; E Mascini; J Verhoef; J Schellekens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-26       Impact factor: 3.267

8.  A large genomic island allows Neisseria meningitidis to utilize propionic acid, with implications for colonization of the human nasopharynx.

Authors:  Maria Chiara E Catenazzi; Helen Jones; Iain Wallace; Jacqueline Clifton; James P J Chong; Matthew A Jackson; Sandy Macdonald; James Edwards; James W B Moir
Journal:  Mol Microbiol       Date:  2014-06-27       Impact factor: 3.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.